换一批
换一批Effect of race/ethnicity on survival in surgically treated intermediate/high risk non-metastatic clear cell renal carcinoma.
作者：
Mattia Luca,Piccinelli [1]
;
Cristina Cano,Garcia [2]
;
Andrea,Panunzio [3]
;
Stefano,Tappero [4]
;
Francesco,Barletta [5]
;
Reha-Baris,Incesu [6]
;
Zhe,Tian [7]
;
Stefano,Luzzago [8]
;
Francesco A,Mistretta [8]
;
Matteo,Ferro [9]
;
Fred,Saad [7]
;
Shahrokh F,Shariat [10]
;
Markus,Graefen [11]
;
Alberto,Briganti [12]
;
Carlo,Terrone [13]
;
Alessandro,Antonelli [14]
;
Felix K H,Chun [15]
;
Ottavio,de Cobelli [8]
;
Gennaro,Musi [8]
;
Pierre I,Karakiewicz [7]
作者单位：
Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada.;Department of Urology, IEO European Institute of Oncology, IRCCS, Milan, Italy.;Scuola di Specializzazione in Urologia, Università degli Studi di Milano, Milan, Italy.
[1]
Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada.;Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt am Main, Frankfurt am Main, Germany.
[2]
Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada.;Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy.
[3]
Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada.;Department of Urology, IRCCS Policlinico San Martino, Genova, Italy.;Department of Surgical and Diagnostic Integrated Sciences (DISC), University of Genova, Genova, Italy.
[4]
Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada.;Division of Experimental Oncology/Unit of Urology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy.
[5]
Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada.;Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
[6]
Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada.
[7]
Department of Urology, IEO European Institute of Oncology, IRCCS, Milan, Italy.;Department of Oncology and Haemato-Oncology, Università degli Studi di Milano, Milan, Italy.
[8]
Department of Urology, IEO European Institute of Oncology, IRCCS, Milan, Italy.
[9]
Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.;Department of Urology, Weill Cornell Medical College, New York, New York, USA.;Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.;Hourani Center of Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan.
[10]
Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
[11]
Division of Experimental Oncology/Unit of Urology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy.
[12]
Department of Urology, IRCCS Policlinico San Martino, Genova, Italy.;Department of Surgical and Diagnostic Integrated Sciences (DISC), University of Genova, Genova, Italy.
[13]
Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy.
[14]
Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt am Main, Frankfurt am Main, Germany.
[15]
DOI
10.1002/jso.27795
PMID
39183540
发布时间
2024-08-26
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
